Complement activation correlates with liver necrosis and fibrosis in chronic hepatitis C

Matthäus Vasel1, Renate Rutz2, Claus Bersch3

  • 1Max-Planck Institute of Biochemistry, Martinsried, Germany; Institute of Immunology, University of Heidelberg, Germany.

Insights

Chronic hepatitis C infection activates complement, a key part of the immune system. Complement activation predicts liver inflammation and fibrosis in patients with hepatitis C.

Area of Science:

  • Immunology
  • Hepatology
  • Virology

Background:

  • Chronic hepatitis C viral infection is known to modulate the complement system.
  • The complement system plays a crucial role in immune responses and inflammation.

Purpose of the Study:

  • To investigate whether complement system analysis can predict liver inflammation and fibrosis in patients with chronic hepatitis C.
  • To assess the correlation between complement activation markers and liver disease severity.

Main Methods:

  • Compared complement activity (CH50) and SC5b-9 levels in 50 chronic hepatitis C patients, 50 healthy controls, and 35 patients with other liver diseases.
  • Analyzed liver biopsies for inflammation and fibrosis using the METAVIR scoring system.
  • Assessed the prevalence of C1q auto-antibodies and their association with disease parameters.

Main Results:

  • Total plasma complement activity (CH50) was diminished in hepatitis C patients, correlating with increased necrosis and higher METAVIR activity scores.
  • The complement activation marker SC5b-9 showed significant correlations with inflammation, activity, and fibrosis scores.
  • C1q auto-antibodies were more prevalent in hepatitis C patients and associated with increased inflammation and fibrosis.

Conclusions:

  • Complement activation contributes to liver inflammation in chronic hepatitis C.
  • Complement system analysis, including CH50, SC5b-9, and C1q auto-antibodies, serves as a valuable predictor of liver inflammation and fibrosis in chronic hepatitis C patients.
  • Targeting complement pathways may offer therapeutic strategies for managing hepatitis C-related liver disease.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.6K